These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Insulin-induced hypoglycemia decreases uptake of 2-[F-18]fluoro-2-deoxy-D-glucose into experimental mammary carcinoma.
    Author: Torizuka T, Fisher SJ, Wahl RL.
    Journal: Radiology; 1997 Apr; 203(1):169-72. PubMed ID: 9122387.
    Abstract:
    PURPOSE: To determine, in an animal study, whether insulin-induced hypoglycemia enhances tumor uptake of 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) in vivo. MATERIALS AND METHODS: Rat mammary tumors were established subcutaneously in Lewis rats. When the tumor was 1-2 cm in diameter, rats were fasted overnight and divided into two groups: control rats (n = 5) that received saline and hypoglycemic rats (n = 5) that received insulin. After 30 minutes, FDG (200 microCi [7.4 MBq]) was given intravenously. One hour after FDG injection (ie, at sacrifice), plasma glucose and insulin levels were measured and F-18 activity in tumor and normal tissues was determined. RESULTS: Mean glucose level was 32.8 mg/dL (1.8 mmol/L) and mean insulin level was 2,831.1 microU/mL (20,315 pmol/L) in the hypoglycemic animals. As compared with the control value, mean FDG uptake in tumor (percentage of injected dose [per gram of tissue] per kilogram of animal weight) significantly decreased with hypoglycemia (0.117 vs 0.331, P = .0001). Mean FDG uptake in the heart and muscle was 9.75 and 5.18 times higher, respectively, in the hypoglycemic rats (P = .0001). Thus, the tumor/muscle uptake ratio was significantly reduced with hypoglycemia (2.15 vs 31.62, P = .0002). CONCLUSION: Tumor targeting with FDG is impaired, not enhanced, by insulin-induced hypoglycemia.
    [Abstract] [Full Text] [Related] [New Search]